Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse...

Area of Science:

• Pharmaceutical Sciences
• Immunology
• Analytical Chemistry

Background:

• Glatiramer acetate (GA) is a complex polypeptide drug for multiple sclerosis with a good safety profile.
• GA's therapeutic epitopes are not fully understood, and it lacks pharmacokinetic/pharmacodynamic markers.
• Generic versions of complex drugs require rigorous characterization to ensure comparability.

Purpose of the Study:

• To characterize Copaxone (glatiramer acetate, GA) and a generic version, Glatopa (USA-FoGA), using orthogonal physicochemical and biological methods.
• To identify potential differences between GA and USA-FoGA that could affect their therapeutic efficacy or immunogenicity.
• To propose relevant assays for the regulatory assessment of nonbiological complex drugs.

Main Methods:

• Utilized standard and high-resolution physicochemical tests (e.g., surface charge analysis, molecular weight determination).
• Employed genome-wide expression profiling of ex vivo activated murine splenocytes.
• Compared intact mixtures of GA and USA-FoGA to detect subtle structural variations.

Main Results:

• High-resolution methods revealed differences between GA and USA-FoGA, including variations in surface charge and a unique high-molecular-weight, hydrophobic polypeptide population in some USA-FoGA lots.
• Genome-wide expression analysis showed differential expression of immune-related genes (7-11%) in splenocytes from mice immunized with GA versus USA-FoGA.
• Physicochemical differences correlated with distinct immune activation profiles, suggesting variations in antigenic epitopes.

Conclusions:

• Physicochemical differences between GA and USA-FoGA can lead to differential immune responses.
• The proposed high-resolution analytical and biological assays are crucial for the regulatory evaluation of nonbiological complex drugs.
• Ensuring comparability of complex drugs like glatiramer acetate is essential for patient safety and treatment efficacy.